Molecular genetics of atrioventricular septal defects

    Research output: Contribution to journalArticle

    31 Citations (Scopus)

    Abstract

    Purpose of review: Atrioventricular septal defects (AVSDs) occur as a clinical feature of several different syndromes, as autosomal dominant defects, and as sporadically occurring malformations. Consequently, it is clear that there is genetic heterogeneity, but until recently, little else was known about the genes involved in the pathogenesis of AVSD. Recent advances in understanding the molecular genetic basis of AVSD are reviewed. Recent findings: Atrioventricular septal defect is most often found associated with trisomy 21 (Down syndrome), but the responsible gene or genes on chromosome 21 have not been identified. However, promising candidates exist, and the current status of those efforts is presented. AVSD not associated with trisomy 21 usually occurs as a sporadic trait with no indication of the genetic basis. The discovery of cysteine rich with EGF domains (CRELD)1 as the first recognized genetic risk factor for AVSD provides new insight into the genetic basis of sporadically occurring AVSD and the potential for genetic overlap with syndromic AVSD. Mutation of CRELD1 increases susceptibility to AVSD but is not alone sufficient to cause the defect, indicating that AVSD is multigenic. Consequently, additional genes must be identified to understand the genetic basis of AVSD. Summary: Because most nonsyndromic cases of AVSD are sporadic, opportunities for genetic analyses in humans are limited. An abundance of candidate genes have been identified through animal models and biochemical studies, but determining which actually contribute to the pathogenesis of AVSD will be difficult. Painstaking investigation of these candidate genes in humans may ultimately be necessary to identify the remaining genetic risk factors for AVSD.

    Original languageEnglish (US)
    Pages (from-to)205-210
    Number of pages6
    JournalCurrent Opinion in Cardiology
    Volume19
    Issue number3
    DOIs
    StatePublished - May 2004

    Fingerprint

    Molecular Biology
    Down Syndrome
    Genes
    Atrioventricular Septal Defect
    Chromosomes, Human, Pair 21
    Genetic Heterogeneity
    Epidermal Growth Factor
    Cysteine
    Animal Models
    Mutation

    Keywords

    • Atrioventricular canal defect
    • Complex traits
    • Endocardial cushions
    • Genetic risk factors
    • Susceptibility genes

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Cite this

    Molecular genetics of atrioventricular septal defects. / Maslen, Cheryl.

    In: Current Opinion in Cardiology, Vol. 19, No. 3, 05.2004, p. 205-210.

    Research output: Contribution to journalArticle

    @article{ee6f70f396c44832a3b81967484abc41,
    title = "Molecular genetics of atrioventricular septal defects",
    abstract = "Purpose of review: Atrioventricular septal defects (AVSDs) occur as a clinical feature of several different syndromes, as autosomal dominant defects, and as sporadically occurring malformations. Consequently, it is clear that there is genetic heterogeneity, but until recently, little else was known about the genes involved in the pathogenesis of AVSD. Recent advances in understanding the molecular genetic basis of AVSD are reviewed. Recent findings: Atrioventricular septal defect is most often found associated with trisomy 21 (Down syndrome), but the responsible gene or genes on chromosome 21 have not been identified. However, promising candidates exist, and the current status of those efforts is presented. AVSD not associated with trisomy 21 usually occurs as a sporadic trait with no indication of the genetic basis. The discovery of cysteine rich with EGF domains (CRELD)1 as the first recognized genetic risk factor for AVSD provides new insight into the genetic basis of sporadically occurring AVSD and the potential for genetic overlap with syndromic AVSD. Mutation of CRELD1 increases susceptibility to AVSD but is not alone sufficient to cause the defect, indicating that AVSD is multigenic. Consequently, additional genes must be identified to understand the genetic basis of AVSD. Summary: Because most nonsyndromic cases of AVSD are sporadic, opportunities for genetic analyses in humans are limited. An abundance of candidate genes have been identified through animal models and biochemical studies, but determining which actually contribute to the pathogenesis of AVSD will be difficult. Painstaking investigation of these candidate genes in humans may ultimately be necessary to identify the remaining genetic risk factors for AVSD.",
    keywords = "Atrioventricular canal defect, Complex traits, Endocardial cushions, Genetic risk factors, Susceptibility genes",
    author = "Cheryl Maslen",
    year = "2004",
    month = "5",
    doi = "10.1097/00001573-200405000-00003",
    language = "English (US)",
    volume = "19",
    pages = "205--210",
    journal = "Current Opinion in Cardiology",
    issn = "0268-4705",
    publisher = "Lippincott Williams and Wilkins",
    number = "3",

    }

    TY - JOUR

    T1 - Molecular genetics of atrioventricular septal defects

    AU - Maslen, Cheryl

    PY - 2004/5

    Y1 - 2004/5

    N2 - Purpose of review: Atrioventricular septal defects (AVSDs) occur as a clinical feature of several different syndromes, as autosomal dominant defects, and as sporadically occurring malformations. Consequently, it is clear that there is genetic heterogeneity, but until recently, little else was known about the genes involved in the pathogenesis of AVSD. Recent advances in understanding the molecular genetic basis of AVSD are reviewed. Recent findings: Atrioventricular septal defect is most often found associated with trisomy 21 (Down syndrome), but the responsible gene or genes on chromosome 21 have not been identified. However, promising candidates exist, and the current status of those efforts is presented. AVSD not associated with trisomy 21 usually occurs as a sporadic trait with no indication of the genetic basis. The discovery of cysteine rich with EGF domains (CRELD)1 as the first recognized genetic risk factor for AVSD provides new insight into the genetic basis of sporadically occurring AVSD and the potential for genetic overlap with syndromic AVSD. Mutation of CRELD1 increases susceptibility to AVSD but is not alone sufficient to cause the defect, indicating that AVSD is multigenic. Consequently, additional genes must be identified to understand the genetic basis of AVSD. Summary: Because most nonsyndromic cases of AVSD are sporadic, opportunities for genetic analyses in humans are limited. An abundance of candidate genes have been identified through animal models and biochemical studies, but determining which actually contribute to the pathogenesis of AVSD will be difficult. Painstaking investigation of these candidate genes in humans may ultimately be necessary to identify the remaining genetic risk factors for AVSD.

    AB - Purpose of review: Atrioventricular septal defects (AVSDs) occur as a clinical feature of several different syndromes, as autosomal dominant defects, and as sporadically occurring malformations. Consequently, it is clear that there is genetic heterogeneity, but until recently, little else was known about the genes involved in the pathogenesis of AVSD. Recent advances in understanding the molecular genetic basis of AVSD are reviewed. Recent findings: Atrioventricular septal defect is most often found associated with trisomy 21 (Down syndrome), but the responsible gene or genes on chromosome 21 have not been identified. However, promising candidates exist, and the current status of those efforts is presented. AVSD not associated with trisomy 21 usually occurs as a sporadic trait with no indication of the genetic basis. The discovery of cysteine rich with EGF domains (CRELD)1 as the first recognized genetic risk factor for AVSD provides new insight into the genetic basis of sporadically occurring AVSD and the potential for genetic overlap with syndromic AVSD. Mutation of CRELD1 increases susceptibility to AVSD but is not alone sufficient to cause the defect, indicating that AVSD is multigenic. Consequently, additional genes must be identified to understand the genetic basis of AVSD. Summary: Because most nonsyndromic cases of AVSD are sporadic, opportunities for genetic analyses in humans are limited. An abundance of candidate genes have been identified through animal models and biochemical studies, but determining which actually contribute to the pathogenesis of AVSD will be difficult. Painstaking investigation of these candidate genes in humans may ultimately be necessary to identify the remaining genetic risk factors for AVSD.

    KW - Atrioventricular canal defect

    KW - Complex traits

    KW - Endocardial cushions

    KW - Genetic risk factors

    KW - Susceptibility genes

    UR - http://www.scopus.com/inward/record.url?scp=2442697452&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=2442697452&partnerID=8YFLogxK

    U2 - 10.1097/00001573-200405000-00003

    DO - 10.1097/00001573-200405000-00003

    M3 - Article

    C2 - 15096951

    AN - SCOPUS:2442697452

    VL - 19

    SP - 205

    EP - 210

    JO - Current Opinion in Cardiology

    JF - Current Opinion in Cardiology

    SN - 0268-4705

    IS - 3

    ER -